News & Events | Page 15 | Englander Institute for Precision Medicine

Join our frequent seminar series, case conferences, consortium meetings, and more!

A Conversation with Dr. Peter Waltman

May 25, 2021

We are pleased to introduce our newest EIPM Member Peter Waltman, Ph.D.

Dr. Waltman is a Research Associate in Bioinformatics at the Englander Institute for Precision Medicine, working in the labs of Director Olivier Elemento, Ph.D., and Andrea Sboner, Ph.D., our Director of Informatics and Computational Biology.

We hope you enjoy learning more about his research interests and background.

Q: What makes your research unique? Can you share some recent findings?

Mentoring Akanksha Verma

May 25, 2021

Being a student is special. The best students are full of life and energy, eager to grasp new concepts and not afraid of stumbling on the way to a fuller understanding. The most important thing to do as a mentor is keep this spirit alive and continue to cultivate it organically. That is why I like to treat my lab as a startup run by students. They’re running the show, making decisions, and free to take the enterprise in whichever direction they think is best.

Predicting How Prostate Cancer Will Behave

May 17, 2021

Molecular characteristics detected in prostate cancers can provide clues that help predict how the disease will progress, according to new research from investigators at Weill Cornell Medicine and NewYork-Presbyterian.

New Grants to Increase Access to Care in Queens & Brooklyn

May 6, 2021

Two Grants Aim to Increase Access to Care and Clinical Trials for Queens and Brooklyn Patients with Blood Cancers

Weill Cornell Medicine has received complementary grants from Genentech and the Leukemia & Lymphoma Society (LLS) to support a new program that aims to address socioeconomic and racial disparities and increase access to clinical trials for underserved patients with blood cancers living in Brooklyn and Queens.

Exploring the Role of Proteins in Obesity

April 26, 2021

A study of proteins circulating in the bloodstream has identified several proteins that may play a causal role in obesity, making them potential targets for drugs and therapies.

Researchers at Weill Cornell Medicine – Qatar examined more than 1,000 proteins in samples taken from individuals in Qatar as part of the Qatar Metabolomics Study on Diabetes, alongside data from European studies. In total, more than 4,600 individuals were involved in the three previous studies. The work was conducted in collaboration with the German Research Center for Environmental Health.

Genomic sequencing in diverse populations

April 13, 2021

Opening Plenary highlights bench-to-bedside aspects of research and clinical treatment

The American Association for Cancer Research Annual Meeting’s Opening Plenary Session: Discovery Science Driving Clinical Breakthroughs featured a broad range of topics—from cutting-edge cell tracking research to advances in our understanding of tumor metabolism to clinical targeting in ethnically diverse populations—illustrating the

Research Unlocks a New Discovery about Controlling Genes

April 9, 2021

Stem Cell Research Unlocks a New Discovery about Controlling Genes

The DNA in our genes contains the instructions needed to manufacture all of the proteins in our cells. These proteins, in turn, do the work that keeps our bodies functioning. Therefore, knowing how individual proteins get made can help us understand the causes of human disease, including cancer.

2021 Quarterly External Newsletter

April 5, 2021

SPRING 2021 NEWSLETTER

Dear friend of the Englander Institute for Precision Medicine,

Researchers create rapid COVID-19 tests, analytics

April 1, 2021

EIPM Researchers create rapid tests, analytics for COVID-19

Two distinct diagnostic tests, a host/pathogen RNA sequencing platform, and spatially resolved tissue mapping tools, were created by a multidisciplinary team of Weill Cornell Medicine and NewYork-Presbyterian Hospital-led researchers and used to map SARS-CoV-2 infections at the height of the initial COVID-19 outbreak in New York City.

Immune cells (red) migrate near the cells that cause fibrosis (green) in late COVID-19. Images courtesy of André Rendeiro.

New Technique Provides Detailed Map of Lung Pathology in COVID-19

March 29, 2021

New Technique Provides Detailed Map of Lung Pathology in COVID-19

A team led by investigators at Weill Cornell Medicine and NewYork-Presbyterian has used advanced technology and analytics to map, at single-cell resolution, the cellular landscape of diseased lung tissue in severe COVID-19 and other infectious lung diseases.